Industry Overview of Intraoperative Neuromonitoring Market

Intraoperative neuromonitoring (IONM) refers to a set of procedures that assist in detecting, monitoring, and verifying nerve function, thus reducing the chances of neurological complications during or after surgeries. These techniques enable surgeons to recognize electrophysiologic changes that occur during head, spine, or neck surgeries, which are vital for the proper placement of implants, extension of incisions, positioning of limbs, and performing retraction techniques. By identifying nerve structures, intraoperative neuromonitoring helps prevent potential damage, allowing surgeons to optimize interventions while maintaining function. This makes IONM systems highly valuable in a range of surgeries, including ENT, emergency, visceral, neuro, cardiothoracic, orthopedic, and vascular surgeries. The intraoperative neuromonitoring market in the US has witnessed significant growth in recent years due to its ability to monitor the nervous system during surgical procedures, thus preventing nerve damage and improving patient outcomes.

How Big Is the Intraoperative Neuromonitoring (IONM) Market?

According to the new market research report by IMARC Group the global intraoperative neuromonitoring (IONM) market size reached a value of US$ 3.3 Billion in 2022. It is projected to reach a value of US$ 5.4 Billion by 2028, exhibiting a CAGR of 7.09% during 2023-2028.

Global Intraoperative Neuromonitoring (IONM) Market Trends and Drivers:

The rise in neurovascular disorders, such as stroke, Parkinson’s disease, epilepsy, and Alzheimer’s disease, and the need to ensure patient safety during complex surgical procedures are the main drivers of the intraoperative neuromonitoring (IONM) market. Furthermore, the growth of the geriatric population, higher spending capacity on advanced healthcare services, and the emergence of medical tourism are also significant factors contributing to market growth. Additionally, the increasing demand for minimally invasive and non-invasive surgeries is promoting the adoption of intraoperative neuromonitoring devices, which is fueling the global market’s growth. Extensive investments in research and development activities are also propelling the market. Other factors such as the need for outsourced monitoring, favorable policies and reimbursement plans by governments, and strategic partnerships between smaller firms and leading market players to expand their product portfolio are also expected to drive growth in the intraoperative neuromonitoring (IONM) market over the forecasted period.

Key Market Segmentation:

The report provides detailed segmentation of the global intraoperative neuromonitoring market based on based on product and services, source type, application and end user and region.

Breakup by Product and Services:

• Systems
• Accessories
• Services

Breakup by Source Type:

• Insourced Monitoring
• Outsourced Monitoring

Breakup by Application:

• Spinal Surgery
• Neurosurgery
• Vascular Surgery
• ENT Surgery
• Orthopedic Surgery
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:

The Major Players in the market are Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc. and Technomed.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800